文献速递乳腺癌放疗放疗物理与技术

术前加速部分乳腺照射早期反应的病理、MRI与FDG PET/CT评估

Evaluation of Early Response to Preoperative Accelerated Partial Breast Irradiation (PAPBI) by Histopathology, Magnetic Resonance Imaging, and 18F-fluorodexoyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT).
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2021-02-26

该研究分析66例低危乳腺癌患者(≥60岁,cT1-2pN0),在接受术前加速部分乳腺照射(10×4 Gy或5×6 Gy)后6周行局部扩大切除。病理评估显示15例(23%)接近完全缓解、28例(42%)部分缓解、23例(35%)无缓解。MRI(RECIST)预测完全缓解的PPV为87.5%、NPV为85%;PET/CT的PPV为25%、NPV为92%,MRI为最准确方法。

要点

  • 66例低危乳腺癌患者中23%达(近)病理完全缓解,42%部分缓解,35%无缓解。
  • MRI(RECIST)预测病理完全缓解的PPV为87.5%,NPV为85%。
  • PET/CT预测病理完全缓解的PPV仅25%,NPV为92%。

核心结论

  • 在低危乳腺癌术前加速部分乳腺照射后,MRI(RECIST)是预测缓解与残留病灶最准确的方法。

研究设计与样本

  • 分析PAPBI试验中66例低危乳腺癌患者(≥60岁;cT1-2pN0),放疗方案为10×4 Gy或5×6 Gy,6周后行局部扩大切除。
  • 放疗前及放疗后5周(术前)行MRI与FDG PET/CT,以病理反应为参照计算MRI与PET/CT的PPV和NPV。

主要发现

  • 66例中病理反应(近)完全缓解15例(23%),部分缓解28例(42%),无缓解23例(35%)。
  • MRI(RECIST)的PPV为87.5%,NPV为85%。
  • PET/CT的PPV为25%,NPV为92%。

关键数值与推荐

  • MRI(RECIST)预测病理完全缓解的PPV为87.5%,NPV为85%。
  • PET/CT预测病理完全缓解的PPV为25%,NPV为92%。
  • 病理(近)完全缓解15/66例(23%),部分缓解28/66例(42%),无缓解23/66例(35%)。

临床怎么用

  • 对于低危乳腺癌术前部分乳腺照射后的疗效评估,可优先采用MRI结合RECIST判断缓解与残留病灶。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to find indicators for early response to radiation therapy in breast cancer. These would be of help in tailoring treatment for individual patients. METHODS AND MATERIALS: We analyzed 66 patients with low-risk breast cancer (≥60 years; cT1-2pN0) treated within the Preoperative Accelerated Partial Breast Irradiation (PAPBI) trial. Patients received radiation therapy (RT; 10 x 4 Gray or 5 x 6 Gray), followed by a wide local excision after 6 weeks. Patients underwent magnetic resonance imaging (MRI) and 18F-fluorodexoyglucose (FDG) positron emission tomography/computed tomography (PET/CT) before RT and 5 weeks after RT, before surgery. We assessed the response to PAPBI using a histopathologic assessment and correlated this with responses on MRI and FDG PET/CT. We calculated the positive predictive values (PPVs) of MRI and PET/CT as the number of true positives (complete response on MRI/normalized at visual evaluation on PET/CT and pathologic complete response) divided by the number of patients with a complete response on MRI/normalized at visual evaluation on PET/CT. Similarly, the negative predictive values (NPVs) of MRI and PET/CT were calculated. RESULTS: The pathologic response was (nearly) complete in 15 (23%) of the 66 patients and partially complete in 28 (42%). The remaining 23 patients (35%) were nonresponders. The PPV of MRI (Response evaluation criteria in solid tumors [RECIST]) was 87.5% and the NPV was 85%. The PPV and NPV of PET/CT were 25% and 92%, respectively. CONCLUSIONS: The most accurate method to predict a response and residual disease after preoperative RT in low-risk breast cancer was MRI, using RECIST.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Bosma SCJ, van der Leij F, Elkhuizen PHM, et al. Evaluation of Early Response to Preoperative Accelerated Partial Breast Irradiation (PAPBI) by Histopathology, Magnetic Resonance Imaging, and 18F-fluorodexoyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT). Int J Radiat Oncol Biol Phys. 2021. PMID: 33647369. doi:10.1016/j.ijrobp.2021.02.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。